SCHEMBL31037673

SCHEMBL31037673

Cc1ccc2c(c1)c1cc(C)ccc1n2-c1cc(-c2ccc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)c(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)c2)c(-n2c3ccc(C)cc3c3cc(C)ccc32)c(-n2c3ccc(C)cc3c3cc(C)ccc32)n1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.33
NPSR1 Q6W5P4 2/20 0.33
HPGD P15428 2/20 0.33
TP53 P04637 2/20 0.33
NPC1 O15118 1/20 0.33
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33
RAB9A P51151 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
MAPT P10636 4/20 0.32
MEN1 O00255 6/20 0.32
KMT2A Q03164 6/20 0.32
ADORA3 P0DMS8 2/20 0.32
DHODH Q02127 1/20 0.32
ADORA2A P29274 1/20 0.32
ADORA1 P30542 1/20 0.32
NLRP3 Q96P20 1/20 0.32
ALDH1A1 P00352 5/20 0.31
LMNA P02545 4/20 0.31
KDM4E B2RXH2 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23855910 1.00 L3MBTL1 (0.33) L3MBTL1NPSR1HPGDTP53NPC1
SCHEMBL31037685 0.97 MAPT (0.33) L3MBTL1NPSR1HPGDTP53NPC1
SCHEMBL23855833 0.97 MAPT (0.33) L3MBTL1NPSR1HPGDTP53NPC1
SCHEMBL31037693 0.87 ALDH1A1 (0.34) L3MBTL1NPSR1HPGDTSHRMAPK1
SCHEMBL23855823 0.87 ALDH1A1 (0.34) L3MBTL1NPSR1HPGDTSHRMAPK1
SCHEMBL30709601 0.86 ALDH1A1 (0.37) L3MBTL1NPSR1HPGDTSHRMAPK1
SCHEMBL23855962 0.85 ADORA3 (0.33) L3MBTL1NPSR1MAPTMEN1KMT2A
SCHEMBL31037688 0.85 ADORA3 (0.33) L3MBTL1NPSR1MAPTMEN1KMT2A
SCHEMBL30709606 0.85 ALDH1A1 (0.38) L3MBTL1NPSR1HPGDTP53NPC1
SCHEMBL23855846 0.85 TP53 (0.36) NPSR1TP53MAPK1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12029116-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2024-07-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12029116-B2 Composition of matter for use in organic light-emitting diodes OPRD1, DRD1, DRD3 L3MBTL1 442/4885NPSR1 1977/4885HPGD 1282/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.